Kircik L - Search Results

1

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

Wollenberg A, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Lacour JP, Spelman L, Katoh N, Saeki H, Poulin Y, Lesiak A, Kircik L, Cho SH, Herranz P, Cork MJ, Peris K, Steffensen LA, Bang B, Kuznetsova A, Jensen TN, Østerdal ML, Simpson EL; ECZTRA 1 and ECZTRA 2 study investigators. Wollenberg A, et al. Among authors: kircik l. Br J Dermatol. 2021 Mar;184(3):437-449. doi: 10.1111/bjd.19574. Epub 2020 Dec 30. Br J Dermatol. 2021. PMID: 33000465 Free PMC article. Clinical Trial.

2

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.

Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, Yang YC, Chiou CF, Dann F, Stevens SR; Unite Study Group. Kircik L, et al. J Drugs Dermatol. 2008 Mar;7(3):245-53. J Drugs Dermatol. 2008. PMID: 18380206 Clinical Trial.

3

Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.

Matheson R, Kempers S, Breneman D, Draelos Z, Johnson CE, Loss R, Hogan DJ, Schoenfeld R, Checketts S, Kircik L, Fivenson D, Hebert AA, Williams J, Hamlin R, Groisser D, Piacquadio D. Matheson R, et al. Among authors: kircik l. J Drugs Dermatol. 2008 Mar;7(3):266-71. J Drugs Dermatol. 2008. PMID: 18380208 Clinical Trial.

4

Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy.

Kircik LH, Liu C, Goffe BS. Kircik LH, et al. J Drugs Dermatol. 2008 Oct;7(10):947-52. J Drugs Dermatol. 2008. PMID: 19112758 Clinical Trial.

5

Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris.

Kircik LH. Kircik LH. J Drugs Dermatol. 2009 Jul;8(7):650-4. J Drugs Dermatol. 2009. PMID: 19588641 Clinical Trial.

6

A nonsteroidal lamellar matrix cream containing palmitoylethanolamide for the treatment of atopic dermatitis.

Kircik L. Kircik L. J Drugs Dermatol. 2010 Apr;9(4):334-8. J Drugs Dermatol. 2010. PMID: 20514790

7

Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study.

Kircik LH. Kircik LH. J Drugs Dermatol. 2011 Jun;10(6):586-90. J Drugs Dermatol. 2011. PMID: 21637899 Clinical Trial.

8

Treatment of mild-to-moderate chronic hand dermatitis with clobetasol propionate 0.05% EF foam: results from an open-label study.

Kircik LH, Tropmann C. Kircik LH, et al. J Drugs Dermatol. 2011 Dec;10(12):1398-402. J Drugs Dermatol. 2011. PMID: 22134563 Clinical Trial.

9

Transepidermal water loss (TEWL) and corneometry with hydrogel vehicle in the treatment of atopic dermatitis: a randomized, investigator-blind pilot study.

Kircik LH. Kircik LH. J Drugs Dermatol. 2012 Feb;11(2):180-4. J Drugs Dermatol. 2012. PMID: 22270199 Clinical Trial.

10

The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.

Kircik LH, Del Rosso JQ. Kircik LH, et al. J Drugs Dermatol. 2012 Oct;11(10):1194-8. J Drugs Dermatol. 2012. PMID: 23134984 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page